Bluejay Diagnostics, Inc.
BJDX
$1.66
-$0.11-6.22%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -30.20% | 3.37% | 40.13% | -6.31% | -1.12% |
| Total Depreciation and Amortization | 38.40% | -30.04% | -0.19% | -1.10% | -3.55% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 100.26% | -360.60% | -69.45% | 5,178.99% | 183.22% |
| Change in Net Operating Assets | 301.80% | 122.43% | -1,056.24% | -59.42% | 92.71% |
| Cash from Operations | 31.85% | 9.98% | -4.20% | 19.41% | 17.19% |
| Capital Expenditure | -- | -450.00% | 99.93% | -662.71% | 59.73% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -450.00% | 99.93% | -662.71% | 59.73% |
| Total Debt Issued | -- | -- | -100.00% | -- | -- |
| Total Debt Repaid | -100.35% | 177.07% | 80.59% | -212,655.56% | 25.00% |
| Issuance of Common Stock | -- | -100.00% | -99.99% | 144.83% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 100.00% | -59.41% | -39,400.00% |
| Cash from Financing | -100.35% | 177.09% | -104.93% | 169.75% | 90,038.71% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 18.43% | 36.87% | -142.66% | 1,092.22% | 115.78% |